DURLAZA Drug Patent Profile
✉ Email this page to a colleague
When do Durlaza patents expire, and what generic alternatives are available?
Durlaza is a drug marketed by Hesp and is included in one NDA.
The generic ingredient in DURLAZA is aspirin. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DURLAZA?
- What are the global sales for DURLAZA?
- What is Average Wholesale Price for DURLAZA?
Summary for DURLAZA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,945 |
| What excipients (inactive ingredients) are in DURLAZA? | DURLAZA excipients list |
| DailyMed Link: | DURLAZA at DailyMed |
Recent Clinical Trials for DURLAZA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Massachusetts General Hospital | Phase 2 |
| Massachusetts Eye and Ear Infirmary | Phase 2 |
| United States Department of Defense | Phase 2 |
US Patents and Regulatory Information for DURLAZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hesp | DURLAZA | aspirin | CAPSULE, EXTENDED RELEASE;ORAL | 200671-001 | Sep 4, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
